The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Viridian Therapeutics Inc (NASDAQ: VRDN) was $13.53 for the day, up 0.22% from the previous closing price of $13.50. In other words, the price has increased by $0.22 from its previous closing price. On the day, 0.68 million shares were traded. VRDN stock price reached its highest trading level at $13.96 during the session, while it also had its lowest trading level at $13.27.
Ratios:
Our analysis of VRDN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.43 and its Current Ratio is at 15.43. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Downgraded its rating to Equal Weight and sets its target price to $27 from $37 previously.
Needham reiterated its Buy rating for the stock on September 11, 2024, while the target price for the stock was revised from $30 to $38.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 27 ’24 when Beetham Thomas W. bought 5,000 shares for $23.41 per share. The transaction valued at 117,050 led to the insider holds 6,000 shares of the business.
Mahoney Stephen F. bought 21,400 shares of VRDN for $499,262 on Sep 27 ’24. The President and CEO now owns 21,400 shares after completing the transaction at $23.33 per share. On Sep 13 ’24, another insider, Fairmount Funds Management LLC, who serves as the Director of the company, bought 1,600,000 shares for $18.75 each. As a result, the insider paid 30,000,000 and bolstered with 3,445,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1107391232 and an Enterprise Value of 596911360. For the stock, the TTM Price-to-Sale (P/S) ratio is 3674.98 while its Price-to-Book (P/B) ratio in mrq is 2.27. Its current Enterprise Value per Revenue stands at 1976.528 whereas that against EBITDA is -2.0.
Stock Price History:
The Beta on a monthly basis for VRDN is 0.62, which has changed by 0.02036202 over the last 52 weeks, in comparison to a change of 0.097913146 over the same period for the S&P500. Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $9.90. The 50-Day Moving Average of the stock is -6.26%, while the 200-Day Moving Average is calculated to be -25.13%.
Shares Statistics:
VRDN traded an average of 964.41K shares per day over the past three months and 963590 shares per day over the past ten days. A total of 80.99M shares are outstanding, with a floating share count of 73.51M. Insiders hold about 9.79% of the company’s shares, while institutions hold 104.69% stake in the company. Shares short for VRDN as of 1744675200 were 11043451 with a Short Ratio of 11.45, compared to 1741910400 on 9998425. Therefore, it implies a Short% of Shares Outstanding of 11043451 and a Short% of Float of 15.340000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Viridian Therapeutics Inc (VRDN) is currently drawing attention from 9.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $-0.98, with high estimates of $-0.84 and low estimates of $-1.31.
Analysts are recommending an EPS of between $-3.29 and $-5.39 for the fiscal current year, implying an average EPS of $-4.04. EPS for the following year is $-3.81, with 10.0 analysts recommending between $-2.73 and $-4.91.
